Higher Intensity Statin Therapy Reduces Clinical Endpoints after Heart Transplantation Independent of Lipid Levels
Coronary artery disease is a leading cause of morbidity and mortality after heart transplantation (HT), resulting from cardiovascular risk factors and those associated with a proinflammatory state. Statins reduce incidence of post-HT cardiac allograft vasculopathy (CAV); it is unknown whether they act through their lipid-lowering effects or through alternative mechanisms.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: J.R. Golbus, S. Adie, S. Hanigan, M. Dorsch, B. Rooks, K.D. Aaronson, M.C. Konerman Tags: 163 Source Type: research
More News: Bone Graft | Cardiology | Cardiovascular | Cholesterol | Heart | Heart Transplant | Lung Transplant | Statin Therapy | Transplant Surgery | Transplants